reference/21319627

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/21319627

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Comparative Study\|Journal Article\|Multicenter Study\|Randomized Controlled Trial\|Research Support, Non-U.S. Gov't
endingPage	797
issn	0140-6736
issueIdentifier	9386
pageRange	789-797
publicationName	Lancet (London, England)
startingPage	789
bibliographicCitation	Wallentin L, Wilcox RG, Weaver WD, Emanuelsson H, Goodvin A, Nyström P, Bylock A; ESTEEM Investigators. Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial. Lancet. 2003 Sep 06;362(9386):789–97. doi: 10.1016/s0140-6736(03)14287-0. PMID: 13678873.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d9afd58f8f928e6e66bab149d1edcb73 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_844449b4c43d381872a60c087de2a806 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e9a62d35099bd8831bb0d8dbc013d212 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fd0ba525b69aa231fa0f9f91a46b0ff5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0762cf1551cdcd9da92d85ec34897a58 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ab4ce737d29b9cd344c73c8c141ea53 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9d2a45bfea1aada1a104a4a201880a2e
date	2003-09-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/13678873 https://doi.org/10.1016/s0140-6736%2803%2914287-0
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5470 https://portal.issn.org/resource/ISSN/0140-6736
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	Oral ximelagatran for secondary prophylaxis after myocardial infarction: the ESTEEM randomised controlled trial
discusses	http://id.nlm.nih.gov/mesh/M0001864 http://id.nlm.nih.gov/mesh/M0388208 http://id.nlm.nih.gov/mesh/M0017642 http://id.nlm.nih.gov/mesh/M0002392 http://id.nlm.nih.gov/mesh/M0016932 http://id.nlm.nih.gov/mesh/M0002072
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011355Q000627 http://id.nlm.nih.gov/mesh/D001384Q000627 http://id.nlm.nih.gov/mesh/D009203Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D017202Q000517 http://id.nlm.nih.gov/mesh/D000284 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D009203Q000517 http://id.nlm.nih.gov/mesh/D001241Q000627 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D001596 http://id.nlm.nih.gov/mesh/D004359 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D055502 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D004311 http://id.nlm.nih.gov/mesh/D010919 http://id.nlm.nih.gov/mesh/D016896
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7969 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9574101 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8198 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2244 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5478933 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID93971978 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID656635 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7181 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_3667f6a0c97490758d7dc9659d01ea34 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11015 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8564 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID73101855 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID6593

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID245255101 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695

Total number of triples: 63.